MGTX (MeiraGTx Corp) רווח למניה בארבעת הרבעונים האחרונים

MeiraGTx Holdings plc (MGTX) has created an autonomous gene-healing environment by integrating its own laboratories with manufacturing. This chart of net income per share YoY ttm growth reflects profitability dynamics, where the metric value of 139.60 serves as a critical benchmark. The active testing phase of the AAV platform is complemented by an expansion strategy in ophthalmology through a partnership with Sanofi and the implementation of Riboswitch AI technology.
MGTX (MeiraGTx Holdings): פילוחים אנליטיים ודוחות לפי אינדיקטורים

This indicator measures the rate of change in rolling earnings per share, allowing investors to assess the efficiency of business capitalization and the justification of the market control premium. By analyzing the year-over-year EPS (TTM) comparison, one can see how the high bioreactor utilization and the seamless operation of MeiraGTx Holdings plc (MGTX) sterile facilities convert into real growth in shareholder value.